Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Changing Stances in 2008 ...
2
Jul 12, 2010 11:43AM

The "minority shareholders" in this instance would be those NOT prepared to follow the advice of the BoD in accepting an offer for the MMP Portfolio which they believed undervalued its worth.

I believe that in your haste to post something, or anything, it was erroneously assumed "minority shareholders" meant those in alignment with the BoD, and I humbly suggest that in future the full thread be read, in context, to avoid similar mistakes.

.

.

.

Be well

Share
New Message
Please login to post a reply